Purification and characterization of FBI-1, a cellular factor that binds to the human immunodeficiency virus type 1 inducer of short transcripts

Molecular and Cellular Biology

Volumn 17, Issue 7, 1997, Pages 3786-3798

  Pessler, Frank ^a   Pendergrast, P Shannon ^a,b   Hernandez, Nouria ^a,b  

^a Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN;

ARTICLE; CONTROLLED STUDY; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN PURIFICATION; VIRUS CELL INTERACTION; VIRUS TRANSCRIPTION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030927823     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.17.7.3786     Document Type: Article

References (75)

1. Ares, M. A., Jr., M. Mangin, and A. M. Weiner. 1985. Orientation-dependent transcriptional activator upstream of a human U2 snRNA gene. Mol. Cell. Biol. 5:1560-1570.
2. Ashfleld, R., A. J. Patel, S. A. Bossone, H. Brown, R. D. Campbell, K. B. Marcu, and N. J. Proudfoot. 1994. MAZ-dependent termination between closely spaced human complement genes. EMBO J. 13:5656-5667.
3. Bender, T. P., C. B. Thompson, and M. W. Kuehl. 1987. Differential expression of c-myb in murine B lymphomas by a block of transcription elongation. Science 237:1473-1476.
4. Bentley, D. L., and M. Groudine. 1986. A block to elongation is largely responsible for decreased transcription of c-myc in differentiated HL60 cells. Nature 321:702-706.
5. Bentley, D. L., and M. Groudine. 1988. Sequence requirements for premature termination of transcription in the human c-myc gene. Cell 53:245-256.
6. Bossone, S. A., C. Asselin, A. J. Patel, and K. B. Marcu. 1992. MAZ, a zinc finger protein, binds to c-myc and C2 gene sequences regulating transcriptional initiation and termination. Proc. Natl. Acad. Sci. USA 89:7452-7456.
7. Brown, S. A., A. N. Imbalzano, and R. E. Kingston. 1996. Activator-dependent regulation of transcriptional pausing on nucleosomal templates. Genes Dev. 10:1479-1490.
8. Buonaguro, L., F. M. Buonaguro, G. Giraldo, and B. Ensoli. 1994. The human immunodeficiency virus type 1 Tat protein transactivates tumor necrosis factor beta gene expression through a TAR-like structure. J. Virol. 68:2677-2682.
9. Carvalho, M., M. Kirkland, and D. Derse. 1993. Protein interactions with DNA elements in variant equine infectious anemia virus enhancers and their impact on transcriptional activity. J. Virol. 67:6586-6595.
10. Catignani Kennedy, G., and W. J. Rutter. 1992. Pur-1, a zinc-finger protein that binds to purine-rich sequences, transactivates an insulin promoter in heterologous cells. Proc. Natl. Acad. Sci. USA 89:11498-11502.
11. Chan, C. L., and R. Landick. 1994. New perspectives on RNA chain elongation and termination by E. coli RNA polymerase, p. 297-321. In R. C. Conaway and J. W. Conaway (ed.), Transcription mechanisms and regulation. Raven Press, New York. N.Y.
12. Chinsky, J. M., M.-C. Maa, V. Ramamurthy, and R. E. Kellems. 1989. Adenosine deaminase gene expression. Tissue-dependent regulation of transcriptional regulation. J. Biol. Chem. 264:14561-14565.
13. Eick, D., R. Berger, A. Polack, and G. W. Bornkamm. 1987. Transcription of c-myc in human mononuclear cells is regulated by an elongation block. Oncogene 2:61-65.
14. Eick, D., and G. W. Bomkamm. 1986. Transcriptional arrest within the first exon is a fast control mechanism in c-myc gene expression. Nucleic Acids Res. 14:8331-8346.
15. Feinberg, M. B., D. Baltimore, and A. D. Frankel. 1991. The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation. Proc. Natl. Acad. Sci. USA 88:4045-4049.
16. Fort, P., L. Marry, M. Piechacyk, A. Bonnieu, P. Jeanteur, and J.-M, Blanchard. 1987. Regulation of c-fos gene expression in hamster fibroblasts: initiation and elongation of transcription and mRNA degradation. Nucleic Acids Res. 15:5657-5667.
17. Fried, M., and D. M. Crothers. 1981. Equilibria and kinetics of lac repressoroperator interactions by polyacrylamide gel electrophoresis. Nucleic Acids Res, 9:6505-6525.
18. Haley, J. D., and M. D. Water-field. 1991. Contributory effects of de novo transcription and premature transcript termination in the regulation of human epidermal growth factor receptor proto-oncogene RNA synthesis. J. Biol. Chem. 266:1746-1753.
19. Harlow, E., and D. Lane. 1988. Antibodies: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
20. Hay, N., H. Skolnik-David, and Y. Aloni. 1982. Attenuation in the control of SV40 expression. Cell 29:183-193.
21. Henry, R. W., C. L. Sadowski, R. Kobayashi, and N. Hernandez. 1995. A TBP-TAF complex required for transcription of human snRNA genes by RNA polymerases II and III. Nature 374:653-657.
22. L 19) promoter. J. Virol. 67:5109-5116.
23. Jeffers, M., and A. Pellicer. 1992. Multiple intragenic elements regulate the expression of the murine N-ras gene. Oncogene 7:2115-2123.
24. Jones, K. A. 1989. HIV trans-activation and transcription control mechanisms. New Biol. 1:127-135.
25. Jones, K. A., P. A. Luciw, and N. Duchange. 1988. Structural arrangements of transcription control domains within the 5′-untranslated leader regions of the HIV-1 and HIV-2 promoters. Genes Dev. 2:1101-1114.
26. Jones, K. A., and B. M. Peterlin. 1994. Control of RNA initiation and elongation at the HIV-1 promoter. Annu. Rev. Biochem. 63:717-743.
27. Kao, S. Y., A. F. Calman, P. A. Luciw, and B. M. Peterlin. 1987. Antitermination of transcription within the long terminal repeat of HIV-1 by tat gene product. Nature 330:489-93.
28. Krumm, A., L. B. Hickey, and M. Groudine. 1995. Promoter-proximal pausing of RNA polymcrase II defines a general rate-limiting step after transcription initiation. Genes Dev. 9:559-572.
29. Krumm, A., T. Meulia, M. Brunvand, and M. Groudine. 1992. The block to transcriptional elongation within the human c-myf gene is determined in the promoter-proximal region. Genes Dev. 6:2201-2213.
30. Krumm, A., T. Meulia, and M. Groudine. 1993. Common mechanisms for the control of eukaryotic transcriptional elongation. Bioessays 15:659-665.
31. Kunkel, G. R., and T. Pederson. 1988. Upstream elements required for efficient transcription of a human U6 RNA gene resemble those of U1 and U2 genes even though a different polymerase is used. Genes Dev. 2:196-204.
32. 5 Rep binding site and the consensus ATP-binding motif of the AAV Rep68 protein. J. Virol. 69:6787-6796.
33. Laspia, M. F., A. P. Rice, and M. B. Mathews. 1989. HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation. Cell 59:283-292.
34. Laspia, M. F., A. P. Rice, and M. B. Mathews. 1990. Synergy between HIV-1 Tat and adenovirus E1A is principally due to stabilization of transcriptional elongation. Genes Dev. 4:2397-2408.
35. Laspia, M. F., P. Wendel, and M. B. Mathews. 1993. HIV-1 tat overcomes ineificient transcriptional elongation in vitro. J. Mol. Biol. 232:732-746.
36. Lee, H., W. Kraus, M. F. Wolfner, and J. T. Lis. 1992. DNA sequence requirements for generating paused polymerase at the start of hsp70. Genes Dev. 6:284-295.
37. Lee, K. J., A. H. Lee, and Y. C. Sung. 1993. Multiple positive and negative cis-acting elements that mediate transactivation by bell in the long terminal repeat of human foamy virus. J. Virol. 67:2317-2326.
38. Lobo, S. M., J. Lister, M. L. Sullivan, and N. Hernandez. 1991. The cloned RNA polymerase II transcription factor IID selects RNA polymerase III to transcribe the human U6 gene in vitro. Genes Dev. 5:1477-1489.
39. Lobo Ruppert, S. M., V. McCulloch, M. Meyer, C. Bautista, M. Falkowski, H. G. Stunnenberg, and N. Hernandez. 1996. Monoclonal antibodies directed against the amino terminal domain of human TBP cross react with TBP from other species. Hybridoma 15:55-68.
40. Lochelt, M., W. Muranyi, and R. M. Flugel. 1993. Human foamy virus genome possesses an internal, Bel-1-dependent and functional promoter. Proc. Natl. Acad. Sci. USA 90:7317-7321,
41. Maa, M. C., J. M. Chinsky, V. Ramamurthy, B. D. Martin, and R. E. Kellems. 1990. Identification of transcription stop sites at the 5′ and 3′ ends of the murine adenosine deaminase gene. J. Biol. Chem. 265:12513-12519.
42. Maderious, A., and S. Chen-Kiang. 1984. Pausing and premature termination of human RNA polymerase II during transcription of adenovirus in vivo and in vitro. Proc. Natl. Acad. Sci. USA 81:5931-5935.
43. Marciniak, R. A., B. J. Calnan, A. D. Frankel, and P. A. Sharp. 1990. HIV-1 Tat protein trans-activates transcription in vitro. Cell 63:791-802.
44. Marciniak, R. A., and P. A. Sharp. 1991. HIV-1 Tat protein promotes formation of more-processive elongation complexes. EMBO J. 10:4189-4196.
45. Margolis, D. M., M. Somasundaran, and M. Green. 1994. Human transcription factor YY1 represses human immunodeficiency virus type 1 production. J. Virol. 68:905-910.
46. Marthas, M. L., R. A. Ramos, B. L. Lohman, K. K. A. Van Rompay, R. E. Unger, C. J. Miller, B. Banapour, N. C. Pedersen, and P. A. Luciw. 1993. Viral determinants of simian immunodeficiency virus (SIV) virulence in rhesus macaques assessed by using attenuated and pathogenic molecular clones of SIVmac. J. Virol. 67:6047-6055.
47. Means, A. L., and P. J. Farnham. 1990. Transcription initiation from the dihydrofolate reductase promoter is positioned by HIP1 binding at the initiation site. Mol. Cell. Biol. 10:653-661.
48. Mechti, N., M. Piechaczyk, J.-M. Blanchard, P. Jeanteur, and B. Lebleu. 1991. Sequence requirements for premature transcription arrest within the first intron of the mouse c-fos gene. Mol. Cell. Biol. 11:2832-2841.
49. Meulia, T., A. Krumm, C. Spencer, and M. Groudine. 1992. Sequences in the human c-myc P2 promoter affect the elongation and premature termination of transcripts initiated from the upstream P1 promoter. Mol. Cell. Biol. 12:4590-4600.
50. Miller. H., C. Asselin, D. Dufort, J.-Q. Yang, K. Gupta, K. B. Marcu, and A. Nepveu. 1989. A cis-acting element in the promoter region of the murine c-myc gene is necessary for transcriptional block. Mol. Cell. Biol. 9:5340-5349.
51. Mok, M., A. Maderious, and S. Chen-Kiang. 1984. Premature termination by human RNA polymerase II occurs temporally in the adenovirus major late transcriptional unit. Mol. Cell. Biol. 4:2031-2040.
52. Narayan, S., S. G. Widen, W. A. Beard, and S. H. Wilson. 1994. Rate of promoter clearance is enhanced by a purified activating transcription factor/ cAMP response element-binding protein. J. Biol. Chem. 269:12755-12763
53. Nyborg, J. K., W. S. Dynan, I. S. Chen, and W. Wachsman. 1988. Binding of host-cell factors to DNA sequences in the long terminal repeat of human T-cell leukemia virus type I: implications for viral gene expression. Proc Natl. Acad. Sci. USA 85:1457-1461.
54. Pendergrast, P. S., and N. Hernandez. 1997. RNA-targeted activators, but not DNA-targeted activators, repress the synthesis of short transcripts at the human immunodeficiency virus type 1 long terminal repeat. J. Virol. 71:910-917.
55. Pendergrast, P. S., D. Morrison, W. P. Tansey, and N. Hernandez. 1996. Mutations in the carboxy-terminal domain of TBP affect the synthesis of human immunodeficiency virus type-1 full-length and short transcripts similarly. J. Virol. 70:5025-5034.
56. Plet, A., D. Eick, and J.-M. Blanchard. 1995. Elongation and premature termination of transcripts initiated from c-fos and c-myc promoters show dissimilar patterns. Oncogene 10:319-328.
57. Rasmssen, E. B., and J. T. Lis. 1995. Short transcripts of the ternary complex provide insight into RNA polymerase II clongational pausing. J. Mol. Biol. 252:522-535.
58. Ratnasabapathy. R., M. Sheldon, L. Johal, and N. Hernandez. 1990. The HlV-1 long terminal repeat contains an unusual element that induces the synthesis of short RNAs from various mRNA and snRNA promoters. Genes Dev. 4:2061-2074.
59. Rickles, R. J., A. L. Darrow, and S. Strickland. 1989. Differentiation-responsive elements in the 5′ region of the mouse tissue plasminogen activator gene confer two-stage regulation by retinoic acid and cyclic AMP in teratocarcinoma cells. Mol. Cell. Biol. 9:1691-1704.
60. Roberts, S., T. Purton, and D. L. Bentley. 1992. A protein-binding site in the c-myc promoter functions as a terminator of RNA polymerase II transcription. Genes Dev. 6:1562-1574.
61. Rougvie, A. E., and J. T. Lis. 1990. Postinitiation transcriptional control in Drosophila melanogaster. Mol. Cell. Biol. 10:6041-6045.
62. Rougvie, A. E., and J. T. Lis. 1988. The RNA polymerase II molecule at the 5′ end of the uninduced hsp70 gene of D. melanogaster is transcriptionally engaged. Cell 54:795-804.
63. Roy, A. L., M. Meisterernst, P. Pognonec, and R. G. Roeder. 1991. Cooperative interaction of an initiator-binding transcription initiation factor and the helix-loop-helix activator USF. Nature 354:245-248.
64. Safrany, G., and R. P. Perry. 1995. The relative contributions of various transcription factors to the overall promoter strength of the mouse ribosomal protein L30 gene. Eur. J. Biochem. 230:1066-1072.
65. Selby, M. J., E. S. Bain, P. A. Luciw, and B. M. Peterlin. 1989. Structure, sequence, and position of the stem-loop in tar determine transcriptional elongation by tat through the HIV-1 long terminal repeat. Genes Dev. 3:547-558.
66. Sheldon, M., R. Ratnasabapathy, and N. Hernandez. 1993. Characterization of the inducer of short transcripts, a human immunodeficiency virus type 1 transcriptional element that activates the synthesis of short RNAs. Mol. Cell. Biol. 13:1251-1263.
67. Sheridan, P. L., M. Schorpp, M. L. Voz, and K. A. Jones. 1995 Cloning of an SNF2/SWI2-related protein that binds specifically to the SPH motifs of the SV40 enhancer and to the HIV-1 promoter. J. Biochem. 270:4575-4588.
68. Smale, S. T., and D. Baltimore. 1989. The "Initiator" as a transcription control element. Cell 57:103-113.
69. Soeller, W. C., C. E. Oh, and T. B. Kornberg. 1993. Isolation of cDNAs encoding the Drnsophila GAGA transcription factor. Mol. Cell. Biol. 13: 7961-7970.
70. Spencer, C. A., and M. Groudine. 1990. Transcription elongation and eukaryotic gene regulation. Oncogene 5:777-785.
71. Strobl, L. J., and D. Eick. 1992. Hold back of RNA polymerase II at the transcription start site mediates down-regulation of c-myc in vivo. EMBO J. 11:3307-3314.
72. Toohey, M. G., and K. A. Jones. 1989. In vitro formation of short RNA polymerase II transcripts that terminate within the HIV-1 and HIV-2promoter-proximal downstream regions. Genes Dev. 3:265-282.
73. Yankulov, K., J. Blau, T. Purton, S. Roberts, and D. L. Bentley. 1994. Transcriptional elongation by RNA polymerase II is stimulated by transaclivators. Cell 77:749-759.
74. Yoon, J.-B., G. Li, and R. G. Roeder. 1994. Characterization of a family of related cellular transcription factors which can modulate human immunodeficiency virus type 1 transcription in vitro. Mol. Cell. Biol. 14:1776-1785.
75. Zoller, M. J., and M. Smith. 1983. Oligonucleotide-directed mutagenesis of DNA fragments cloned into M13 vectors. Methods Enzymol. 100:468-500.